EP1173466A4 - Verfahren zur vermeidung der bindung von leukozyten an fibrinogen - Google Patents

Verfahren zur vermeidung der bindung von leukozyten an fibrinogen

Info

Publication number
EP1173466A4
EP1173466A4 EP00930252A EP00930252A EP1173466A4 EP 1173466 A4 EP1173466 A4 EP 1173466A4 EP 00930252 A EP00930252 A EP 00930252A EP 00930252 A EP00930252 A EP 00930252A EP 1173466 A4 EP1173466 A4 EP 1173466A4
Authority
EP
European Patent Office
Prior art keywords
fibrinogen
leukocyte adhesion
inhibiting leukocyte
inhibiting
adhesion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00930252A
Other languages
English (en)
French (fr)
Other versions
EP1173466A1 (de
Inventor
David P O'connell
Elisabeth Wann
Magnus Hook
Timothy J Foster
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin
Texas A&M University System
Original Assignee
College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin
Texas A&M University System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin, Texas A&M University System filed Critical College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin
Publication of EP1173466A1 publication Critical patent/EP1173466A1/de
Publication of EP1173466A4 publication Critical patent/EP1173466A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
EP00930252A 1999-04-28 2000-04-28 Verfahren zur vermeidung der bindung von leukozyten an fibrinogen Withdrawn EP1173466A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13240499P 1999-04-28 1999-04-28
US132404P 1999-04-28
PCT/US2000/011685 WO2000064925A1 (en) 1999-04-28 2000-04-28 Method of inhibiting leukocyte adhesion to fibrinogen

Publications (2)

Publication Number Publication Date
EP1173466A1 EP1173466A1 (de) 2002-01-23
EP1173466A4 true EP1173466A4 (de) 2002-10-16

Family

ID=22453897

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00930252A Withdrawn EP1173466A4 (de) 1999-04-28 2000-04-28 Verfahren zur vermeidung der bindung von leukozyten an fibrinogen

Country Status (4)

Country Link
EP (1) EP1173466A4 (de)
AU (1) AU4810600A (de)
CA (1) CA2367830A1 (de)
WO (1) WO2000064925A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002256985B8 (en) 2001-01-26 2008-03-20 Inhibitex, Inc Monoclonal antibodies to the ClfA protein and method of use in treating or preventing infections
US9181329B2 (en) 2007-08-31 2015-11-10 The University Of Chicago Methods and compositions related to immunizing against Staphylococcal lung diseases and conditions
CN101951948B (zh) 2007-08-31 2015-12-09 芝加哥大学 与针对葡萄球菌性肺部疾病和病症进行免疫相关的方法和组合物
AU2012216332B8 (en) * 2008-01-31 2015-04-30 The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth, Near Dublin Treatment of microbial infections
JP5709527B2 (ja) * 2008-01-31 2015-04-30 ザ プロボスト フェローズ アンドスカラーズ オブ ザ カレッジ オブ ザ ホーリー アンド アンディバイデッドトリニティー オブ クイーン エリザベス ニア ダブリン 微生物感染症の治療
WO2011005341A2 (en) 2009-04-03 2011-01-13 University Of Chicago Compositions and methods related to protein a (spa) variants
CA2768485C (en) 2009-07-16 2018-12-04 Timothy Foster Treatment of staphylococci infections using recombinant fibrinogen binding protein clumping factor a
CA2803298C (en) 2010-07-02 2020-07-14 The University Of Chicago Compositions and methods related to protein a (spa) variants
US8945588B2 (en) 2011-05-06 2015-02-03 The University Of Chicago Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6008341A (en) * 1994-08-22 1999-12-28 The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin S. aureus fibrinogen binding protein gene

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
O'CONNELL D P ET AL: "The fibrinogen-binding MSCRAMM (clumping factor) of Staphylococcus aureus has a Ca2+-dependent inhibitory site.", JOURNAL OF BIOLOGICAL CHEMISTRY, (1998 MAR 20) 273 (12) 6821-9., XP002195398 *

Also Published As

Publication number Publication date
CA2367830A1 (en) 2000-11-02
WO2000064925A1 (en) 2000-11-02
WO2000064925A9 (en) 2002-06-27
AU4810600A (en) 2000-11-10
EP1173466A1 (de) 2002-01-23

Similar Documents

Publication Publication Date Title
HRP970604B1 (en) Novel heterocycles as inhibitors of leukocyte adhesion and as antagonists of vla-4
PL344488A1 (en) Method of bonding metal parts to plastic materials
HK1045157A1 (zh) 抑制vla-4介導的白細胞粘着的化合物
PL339173A1 (en) Derivatives of benzamidine as inhibitors of factor xa
IL133639A0 (en) Dipeptide and related compounds which inhibit leukocyte adhesion mediated by vla-4
IL149118A0 (en) Inhibitors of neuraminidases
IL133641A0 (en) Compounds which inhibit leukocyte adhesion mediated by vla-4
HUP0002682A3 (en) Dipeptide compounds which inhibit leukocyte adhesion mediated by vla-4
PL320995A1 (en) Fibronectin adhesion inhibitors
GB2345790B (en) Method for improving adhesion to copper
EG23980A (en) Potassium salt of (s)-omeprazole
HUP9801991A3 (en) Proline derivatives useful as inhibitors of human leukocyte elastase
IL144274A0 (en) Derivatives of monosaccharides as cell adhesion inhibitors
EP1173466A4 (de) Verfahren zur vermeidung der bindung von leukozyten an fibrinogen
EP1049716A4 (de) Aufreinigung von fibrinogen
AU1183101A (en) Method relating to anodic bonding
HK1041270A1 (en) 2,-3-o-isoproylidene derivatives of monosaccharides as cell adhesion inhibitors
IL138601A0 (en) Pyrrolidines as inhibitors of neuraminidases
HK1046146B (zh) 可以抑制由vla-4介導的白細胞粘着的焦谷氨酸衍生物及相關化合物
HK1044549B (zh) 可以抑制由vla-4介導的白細胞粘着的化合物
GB2389182B (en) Method of purifying b-secretase
AU3899200A (en) Treatment to lower platelet adhesiveness
PL336405A1 (en) Method of purifying isoquinoline
GB9924752D0 (en) Method of construction
PL331398A1 (en) Method of purifying crude salicylic acid

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20011030

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RIC1 Information provided on ipc code assigned before grant

Free format text: 7C 07K 1/00 A, 7C 07K 14/00 B, 7C 07K 17/00 B, 7C 07K 14/31 B

A4 Supplementary search report drawn up and despatched

Effective date: 20020902

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20021116